FBXW7 Inactivation Induces Cellular Senescence Via Accumulation of P53
Overview
Affiliations
F-box and WD repeat domain containing 7 (FBXW7) acts as a substrate receptor of SKP1-CUL1-F-box (SCF) E3 ubiquitin ligase and plays crucial roles in the regulation of several cellular processes, including cell growth, division, and differentiation, by targeting diverse key regulators for degradation. However, its role in regulating cellular senescence remains elusive. Here, we found that FBXW7 inactivation by siRNA-based knockdown or CRISPR/Cas9-based knockout induced significant cellular senescence in p53 wild-type cells, but not in p53 mutant or null cells, along with activation of both the p53/p21 and p16/Rb pathways. Simultaneous p53 inactivation abrogated senescence and cell growth arrest induced by FBXW7 deficiency as well as the alteration of both the p53/p21 and p16/Rb pathways. Moreover, Fbxw7 deletion accelerated replicative senescence of primary mouse embryonic fibroblasts in a p53-dependent manner. In addition, FBXW7 deletion induced the senescence-associated secretory phenotype to trigger secondary senescence. Importantly, in a radiation-induced senescence mouse model, simultaneous deletion of p53 rescued accelerated senescence and aging caused by Fbxw7 loss. Thus, our study uncovered a novel role for FBXW7 in the regulation of senescence by eliminating p53.
Hou J, Lin Y, Zhu C, Chen Y, Lin R, Lin H Adv Sci (Weinh). 2024; 11(30):e2402477.
PMID: 38874373 PMC: 11321630. DOI: 10.1002/advs.202402477.
Advances of E3 ligases in lung cancer.
Yu J, Zhao Y, Xie Y Biochem Biophys Rep. 2024; 38:101740.
PMID: 38841185 PMC: 11152895. DOI: 10.1016/j.bbrep.2024.101740.
Ramoni D, Coco S, Rossi G, Dellepiane C, Bennicelli E, Santamaria S Lung. 2024; 202(2):197-210.
PMID: 38480620 PMC: 11009777. DOI: 10.1007/s00408-024-00675-5.
Ma J, Xiong Z, Cai X, Li X, Ren S, An S Aging (Albany NY). 2024; 16(5):4541-4562.
PMID: 38428403 PMC: 10968698. DOI: 10.18632/aging.205607.
FBXW7 in breast cancer: mechanism of action and therapeutic potential.
Chen S, Leng P, Guo J, Zhou H J Exp Clin Cancer Res. 2023; 42(1):226.
PMID: 37658431 PMC: 10474666. DOI: 10.1186/s13046-023-02767-1.